Hao Liu1, Zhi Song2, Da-Guang Liao1, Tian-Yi Zhang1, Feng Liu1, Wen Zheng2, Kui Luo1, Liang Yang1. 1. Department of Neurosurgery, The Third Xiangya Hospital of Central South University Changsha 410013, Hunan, P.R. China. 2. Department of Neurology, The Third Xiangya Hospital of Central South University Changsha 410013, Hunan, P.R. China.
Abstract
BACKGROUND: A number of studies have suggested that the Cyclin D1 (CCND1) G870A polymorphism was associated with susceptibility to various cancers. In the present study, we aimed to investigate the association between CCND1 G870A polymorphism and the risk of glioma in a Chinese population. MATERIALS AND METHODS: CCND1 genotyping was determined by the PCR-RFLP method. The χ (2) test was used to assess for any deviation of the genotype frequencies from Hardy-Weinberg equilibrium and to compare the genotype distributions among glioma patients and healthy control subjects. We calculated the odds ratios (ORs) and 95% confidence intervals (95% CIs) by using unconditional logistic regression. RESULTS: The A allele frequency was higher in cases than that in controls (49.40% vs. 36.39%), and this difference was statistically significant (P = 0.001). Using the G allele as the reference allele, the subjects carrying the A allele had 3.926-fold increase in the risk of glioma (95% CI, 2.172-7.889), and p-value was significant (P = 0.007). Compared to individuals with the GG genotype, individuals with the AA genotype exhibited significantly increased glioma risk (OR = 3.661, 95% CI: 1.658-6.287, P = 0.01). CONCLUSION: Our results suggest that the CCND1 G870A polymorphism may contribute to the susceptibility to glioma in Chinese population.
BACKGROUND: A number of studies have suggested that the Cyclin D1 (CCND1) G870A polymorphism was associated with susceptibility to various cancers. In the present study, we aimed to investigate the association between CCND1G870A polymorphism and the risk of glioma in a Chinese population. MATERIALS AND METHODS:CCND1 genotyping was determined by the PCR-RFLP method. The χ (2) test was used to assess for any deviation of the genotype frequencies from Hardy-Weinberg equilibrium and to compare the genotype distributions among gliomapatients and healthy control subjects. We calculated the odds ratios (ORs) and 95% confidence intervals (95% CIs) by using unconditional logistic regression. RESULTS: The A allele frequency was higher in cases than that in controls (49.40% vs. 36.39%), and this difference was statistically significant (P = 0.001). Using the G allele as the reference allele, the subjects carrying the A allele had 3.926-fold increase in the risk of glioma (95% CI, 2.172-7.889), and p-value was significant (P = 0.007). Compared to individuals with the GG genotype, individuals with the AA genotype exhibited significantly increased glioma risk (OR = 3.661, 95% CI: 1.658-6.287, P = 0.01). CONCLUSION: Our results suggest that the CCND1G870A polymorphism may contribute to the susceptibility to glioma in Chinese population.
Authors: Maosheng Huang; Margaret R Spitz; Jian Gu; J Jack Lee; Jie Lin; Scott M Lippman; Xifeng Wu Journal: Carcinogenesis Date: 2006-04-25 Impact factor: 4.944
Authors: Y Zheng; H Shen; E M Sturgis; L E Wang; S A Eicher; S S Strom; M L Frazier; M R Spitz; Q Wei Journal: Carcinogenesis Date: 2001-08 Impact factor: 4.944
Authors: Alan G Casson; Zuoyu Zheng; Susan C Evans; Laurette Geldenhuys; Sander Veldhuyzen van Zanten; Paul J Veugelers; Geoffrey A Porter; Duane L Guernsey Journal: Cancer Date: 2005-08-15 Impact factor: 6.860
Authors: Sanjay Shete; Fay J Hosking; Lindsay B Robertson; Sara E Dobbins; Marc Sanson; Beatrice Malmer; Matthias Simon; Yannick Marie; Blandine Boisselier; Jean-Yves Delattre; Khe Hoang-Xuan; Soufiane El Hallani; Ahmed Idbaih; Diana Zelenika; Ulrika Andersson; Roger Henriksson; A Tommy Bergenheim; Maria Feychting; Stefan Lönn; Anders Ahlbom; Johannes Schramm; Michael Linnebank; Kari Hemminki; Rajiv Kumar; Sarah J Hepworth; Amy Price; Georgina Armstrong; Yanhong Liu; Xiangjun Gu; Robert Yu; Ching Lau; Minouk Schoemaker; Kenneth Muir; Anthony Swerdlow; Mark Lathrop; Melissa Bondy; Richard S Houlston Journal: Nat Genet Date: 2009-07-05 Impact factor: 38.330
Authors: Preetha Rajaraman; Sophia S Wang; Nathaniel Rothman; Merideth M Brown; Peter M Black; Howard A Fine; Jay S Loeffler; Robert G Selker; William R Shapiro; Stephen J Chanock; Peter D Inskip Journal: Cancer Epidemiol Biomarkers Prev Date: 2007-08 Impact factor: 4.254